Skip to main content
. 2023 Jun 29;19(6):e1011469. doi: 10.1371/journal.ppat.1011469

Fig 2. Neutralization profiles of pseudoviruses from the different study arms of the AMP trials.

Fig 2

Box plots illustrate neutralization data (IC80 titers, median and range) of all viruses against 8 bnAbs in clinical development and separated according to study arms in (A) HVTN703/HPTN081 (placebo n = 33, low dose n = 35, high dose n = 21) and (B) HVTN704/HPTN085 (placebo n = 47, low dose n = 42, high dose n = 38). Solid bars represent median titers.